Vacunas en Adultos mayores:
- 2024 Efficacy and Safety of Respiratory Syncytial Virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons
- 2024 Respiratory Syncytial Virus Prefusion F Protein Vaccine is efficacious in older adults with underlying medical conditions
- 2023 Respiratory Syncytial Virus Prefusion F protein vaccine in older adults
Epidemiología:
- 2022 Determinants of RSV epidemiology following suppression through pandemic contact restrictions
- 2022 Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA.
- 2021 The Global Epidemiology of RSV in Community and Hospitalized Care: Findings From 15 Countries
- 2021 Paying the immunity debt with interest
- 2018 Respiratory Syncytial Virus Seasonality: A Global Overview